Now our aim was to determine the follow-up effects of anti-TNF therapy on metabolic biomarkers including PON/ARE, MPO, lipids, and adipokines and to link this to various immune-inflammatory effects, as well as vascular pathophysiology in RA and AS. Here, PON1 is linked to rheumatoid arthritis.